MSL on-demand

An Opportunity to Prevent and Fight Back with Kevin Winthrop
1hr

Keynote speaker: Prof Kevin Winthrop
Chair: A/Prof Peter Wong 

Topics discussed:
Prevention and management of opportunistic infections and COVID-19 in patients with Immune-Mediated Inflammatory diseases

The content on this page has been adapted from a live webinar held on 31 March 2022. This educational program is initiated by AbbVie for the purpose of enhancing medical knowledge and scientific exchange. The slide deck was created by the presenters. The views and opinions expressed in the presentation are those of the presenter and do not necessarily reflect those of AbbVie. AbbVie does not endorse the use of unregistered products or products outside of their registered indications.

Have a question for your Medical Science Liaison?  

Divya Mehra

Divya Mehra, B Pharm, PhD
(NSW/ACT/QLD)
Medical Science Liaison
Email: divya.mehra@abbvie.com
Ph: 0435 285 078

Adrian Tong

Adrian Tong, PhD
(VIC/SA/WA/TAS)
Medical Science Liaison
Email: adrian.tong@abbvie.com
Ph: 0434 676 102

Esme Shepherd

Esme Shepherd (VIC/TAS/SA/WA/NT)
Medical Science Liaison
Email:esme.shepherd@abbvie.com
Ph: 0466 649 354

Reda Hamdi

Reda Hamdi (NSW/QLD/ACT)
Medical Science Liaison
Email: reda.hamdi@abbvie.com
Ph: 0412 792 868

Francis Shand

Francis Shand, PhD
 (VIC/TAS/SA/WA)
Medical Science Liaison
Email: francis.shand@abbvie.com
Ph: 0435 100 042

Mali Ghadiri

Mali Ghadiri, PharmD, PhD
(NSW/ACT/QLD)
Medical Science Liaison
Email: mali.ghadiri@abbvie.com
Ph: 0422 991 452

This communication is intended for a healthcare professional audience only and may also contain information that is proprietary, confidential, or exempt from disclosure. Please do not distribute this email, attachment, or any associated content. If you are not the intended recipient, please note that any other dissemination, distribution, use or copying of this communication is strictly prohibited. Anyone who receives this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer.

ABBV-AU-00081-MC April 2022

Copyright © 2022 AbbVie Pty Ltd. Mascot NSW 2020 Australia.

Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates.
No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.